"DNA Methylation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Addition of methyl groups to DNA. DNA methyltransferases (DNA methylases) perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.
| Descriptor ID |
D019175
|
| MeSH Number(s) |
G02.111.035.538.161 G02.111.218 G03.059.538.161 G05.206
|
| Concept/Terms |
DNA Methylation- DNA Methylation
- DNA Methylations
- Methylation, DNA
- Methylations, DNA
|
Below are MeSH descriptors whose meaning is more general than "DNA Methylation".
Below are MeSH descriptors whose meaning is more specific than "DNA Methylation".
This graph shows the total number of publications written about "DNA Methylation" by people in this website by year, and whether "DNA Methylation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 2 | 1 | 3 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 2 | 3 | 5 |
| 2003 | 5 | 1 | 6 |
| 2004 | 2 | 4 | 6 |
| 2005 | 3 | 4 | 7 |
| 2006 | 1 | 2 | 3 |
| 2007 | 6 | 3 | 9 |
| 2008 | 4 | 4 | 8 |
| 2009 | 3 | 6 | 9 |
| 2010 | 6 | 8 | 14 |
| 2011 | 17 | 9 | 26 |
| 2012 | 19 | 14 | 33 |
| 2013 | 11 | 13 | 24 |
| 2014 | 15 | 13 | 28 |
| 2015 | 17 | 21 | 38 |
| 2016 | 25 | 17 | 42 |
| 2017 | 11 | 9 | 20 |
| 2018 | 22 | 13 | 35 |
| 2019 | 8 | 10 | 18 |
| 2020 | 12 | 15 | 27 |
| 2021 | 4 | 13 | 17 |
| 2022 | 4 | 10 | 14 |
| 2023 | 3 | 14 | 17 |
| 2024 | 10 | 6 | 16 |
| 2025 | 7 | 8 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA Methylation" by people in Profiles.
-
Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types. Cancer Res Commun. 2025 Nov 01; 5(11):1952-1966.
-
Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial. J Clin Oncol. 2025 Sep 20; 43(27):3032-3040.
-
The role of extent of resection, chemoradiation, and MGMT promoter methylation in overall survival in a large cohort of IDH-wildtype glioblastoma. Neurosurg Focus. 2025 08 01; 59(2):E9.
-
Longitudinal transcriptomic and epigenetic analysis of the blood in two astronauts. Sci Rep. 2025 Jul 26; 15(1):27175.
-
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Haematologica. 2026 Jan 01; 111(1):158-167.
-
Genetic contributions to epigenetic-defined endotypes of allergic phenotypes in children. Am J Hum Genet. 2025 Jul 03; 112(7):1610-1624.
-
Accelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung disease. Eur Respir J. 2025 Jun; 65(6).
-
Noninvasive prognostication of hepatocellular carcinoma based on cell-free DNA methylation. PLoS One. 2025; 20(4):e0321736.
-
Newborn blood DNA methylation and childhood asthma: findings from the ECHO program. Int J Epidemiol. 2025 Apr 12; 54(3).
-
Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients. Acta Neuropathol. 2025 04 09; 149(1):32.